Phase I/II trial of weekly irinotecan and docetaxel with the addition of celecoxib in advanced non-small cell lung cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel; Irinotecan
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Jul 2012 Biomarkers information updated
- 24 May 2007 New trial record.